December 31, 2025 · Form 4 insider transaction
Rahmer Peter bought 994 shares of Relay Therapeutics, Inc. at $2.99 per share, a transaction worth $3.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 29 days after the transaction.
The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.; In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025.; Includes 108,919 shares underlying restricted stock units ("RSUs").